Since its inception, Jubilant’s business model of providing functional services across discovery and preclinical portfolio has received wide acceptance and is demonstrated by the continuing long term and sustainable partnerships that the Jubilant Biosys has been able to enter.

Jubilant’s Functional Discovery Services

Our functional discovery services are designed to align with collaborators’ therapeutic strategies across lead generation, preclinical and clinical development platforms.

The Company provides functional services across the entire value chain of discovery and development to include:

Industries We Serve

Collaborating with global top-10, mid-sized, virtual pharmaceutical and biotech companies, Jubilant Biosys has rapidly emerged as a leading partner for pharmaceutical and biotechnology companies worldwide and become leading contract research organisation. It also collaborates with the world’s leading academic Institutions and research foundations. Innovative and rigorous small molecule science in early stage drug discovery, excellence in execution and absolute integrity combined with flexible business models has enabled Jubilant Biosys to deliver valuable outcomes in a relatively short period.

 For more information on our functional drug discovery services, please drop your contact details here. Our team will get in touch with at the latest.